[HTML][HTML] Difluoromethyl-1, 3, 4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity
E Cellupica, G Caprini, P Cordella, C Cukier… - Journal of Biological …, 2023 - ASBMB
Histone deacetylase 6 (HDAC6) is an attractive drug development target because of its role
in the immune response, neuropathy, and cancer. Knockout mice develop normally and …
in the immune response, neuropathy, and cancer. Knockout mice develop normally and …
[HTML][HTML] Difluoromethyl-1, 3, 4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity
E Cellupica, G Caprini, P Cordella… - The Journal of …, 2023 - ncbi.nlm.nih.gov
Abstract Histone deacetylase 6 (HDAC6) is an attractive drug development target because
of its role in the immune response, neuropathy, and cancer. Knockout mice develop …
of its role in the immune response, neuropathy, and cancer. Knockout mice develop …
Difluoromethyl-1, 3, 4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity.
E Cellupica, G Caprini, P Cordella… - The Journal of …, 2022 - europepmc.org
Abstract Histone deacetylase 6 (HDAC6) is an attractive drug development target because
of its role in the immune response, neuropathy, and cancer. Knockout mice develop …
of its role in the immune response, neuropathy, and cancer. Knockout mice develop …
[HTML][HTML] Difluoromethyl-1, 3, 4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity
E Cellupica, G Caprini, P Cordella, C Cukier… - Journal of Biological …, 2023 - Elsevier
Histone deacetylase 6 (HDAC6) is an attractive drug development target because of its role
in the immune response, neuropathy, and cancer. Knockout mice develop normally and …
in the immune response, neuropathy, and cancer. Knockout mice develop normally and …
Difluoromethyl-1, 3, 4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity
E Cellupica, G Caprini, P Cordella… - The Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Histone deacetylase 6 (HDAC6) is an attractive drug development target because of its role
in the immune response, neuropathy, and cancer. Knockout mice develop normally and …
in the immune response, neuropathy, and cancer. Knockout mice develop normally and …
Difluoromethyl-1, 3, 4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity
E Cellupica, G Caprini, P Cordella, C Cukier… - THE JOURNAL OF …, 2023 - air.unimi.it
Abstract Histone deacetylase 6 (HDAC6) is an attractive drug development target due to its
role in the immune response, neuropathy, and cancer. Knock-out mice develop normally …
role in the immune response, neuropathy, and cancer. Knock-out mice develop normally …
[PDF][PDF] Difluoromethyl-1, 3, 4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity
E Cellupica, G Caprini, P Cordella, C Cukier, G Fossati… - J. Biol. Chem, 2023 - air.unimi.it
Histone deacetylase 6 (HDAC6) is an attractive drug development target because of its role
in the immune response, neuropathy, and cancer. Knockout mice develop normally and …
in the immune response, neuropathy, and cancer. Knockout mice develop normally and …
Difluoromethyl-1, 3, 4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity.
E Cellupica, G Caprini, P Cordella… - The Journal of …, 2022 - europepmc.org
Histone deacetylase 6 (HDAC6) is an attractive drug development target due to its role in the
immune response, neuropathy, and cancer. Knock-out mice develop normally and have no …
immune response, neuropathy, and cancer. Knock-out mice develop normally and have no …